Celenus Sp. z o.o. sp.k.
- Address
- lock Available on a paid plan
Digestive System Diseases
At Celenus Sp. z o.o. sp.k. in Belchatów, research in Digestive System Diseases focuses on ulcerative colitis, with studies designed to assess whether new treatment options can improve symptoms and support better intestinal healing for people with active disease.
- Evaluating a new therapy for moderately to severely active ulcerative colitis
- Measuring endoscopic improvement alongside symptomatic remission
- Exploring better ways to manage chronic inflammatory bowel disease
This area of research aims to strengthen treatment options for patients who need more effective control of ongoing digestive inflammation.
Cardiovascular Diseases
The site also conducts clinical research in Cardiovascular Diseases, with attention to type 2 diabetes, hypertension, and broader cardiovascular disease. These trials are focused on understanding whether new treatment combinations can better protect patients at risk of serious heart-related complications.
- Testing a treatment approach for people with type 2 diabetes, high blood pressure, and established cardiovascular disease
- Assessing whether therapy can reduce major heart failure and cardiovascular events
- Supporting improved long-term management of cardiometabolic risk
Overall, this research area is centered on improving outcomes for patients with overlapping metabolic and heart conditions, where preventing serious events is a major goal.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Boehringer Ingelheim Espana S.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Celenus Sp. z o.o. sp.k.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Obefazimod for Induction in Adults with Moderately to Severely Active Ulcerative Colitis: Randomized, Double‑Blind, Placebo‑Controlled III Trial | Abivax | Phase III | Not Recruiting | Jun 2023 | Jun 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 690517 | 1 | Unknown | 2025-10-15 | 2025-10-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.